Skip to content

Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic Esophagitis

Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic Esophagitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06972147
Acronym
FIREO
Enrollment
40
Registered
2025-05-14
Start date
2025-07-01
Completion date
2026-08-01
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic Esophagitis

Brief summary

A new clinical entity of eosinophilic esophagitis, Food Induced Immediate Response of the Esophagus or FIRE, has been described since 2020. Diagnostic criteria are not clearly established. Specific questioning is necessary for differential diagnosis, such as the oro-pharyngeal syndrome notably described in pollinics, or a mechanical blockage strictly speaking linked to esophagitis. The aim is to obtain epidemiological data on this entity.

Interventions

None listed

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Patients over 6 and under 18 years of age at the time of inclusion * Follow-up in the allergology unit of Angers University Hospital for eosinophilic esophagitis

Exclusion criteria

* Patients or legal representative with severe communication or language comprehension difficulties * Patients or legal representatives objecting to study participation

Design outcomes

Primary

MeasureTime frameDescription
diagnosis of FIRE syndromeday 1symptoms such as pain, pressure, choking or narrowing, in the oesophagus or retrosternum, within 10 minutes of ingestion, lasting a maximum of 120 minutes, when a specific food is ingested

Countries

France

Contacts

CONTACTAnne HOPPE, MD
anne.hoppe@chu-angers.fr241353637
PRINCIPAL_INVESTIGATORAnne HOPPE

University Hospital of Angers

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026